EMA — authorised 22 November 2018
- Marketing authorisation holder: SHIRE PHARMACEUTICALS IRELAND LTD
- Status: approved
🇪🇺 Takhzyro in European Union
EMA authorised Takhzyro on 22 November 2018
Marketing authorisation
Takhzyro in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Takhzyro approved in European Union?
Yes. EMA authorised it on 22 November 2018.
Who is the marketing authorisation holder for Takhzyro in European Union?
SHIRE PHARMACEUTICALS IRELAND LTD holds the EU marketing authorisation.